» Articles » PMID: 27353086

MLP and CARP Are Linked to Chronic PKCα Signalling in Dilated Cardiomyopathy

Abstract

MLP (muscle LIM protein)-deficient mice count among the first mouse models for dilated cardiomyopathy (DCM), yet the exact role of MLP in cardiac signalling processes is still enigmatic. Elevated PKCα signalling activity is known to be an important contributor to heart failure. Here we show that MLP directly inhibits the activity of PKCα. In end-stage DCM, PKCα is concentrated at the intercalated disc of cardiomyocytes, where it is sequestered by the adaptor protein CARP in a multiprotein complex together with PLCβ1. In mice deficient for both MLP and CARP the chronic PKCα signalling chain at the intercalated disc is broken and they remain healthy. Our results suggest that the main role of MLP in heart lies in the direct inhibition of PKCα and that chronic uninhibited PKCα activity at the intercalated disc in the absence of functional MLP leads to heart failure.

Citing Articles

Importance of N2BA Titin in Maintaining Cardiac Homeostasis and Its Role in Dilated Cardiomyopathy.

van der Pijl R, Nusayr E, Strom J, Slater R, Gohlke J, Hourani Z Circ Heart Fail. 2025; :e012083.

PMID: 39932400 PMC: 11905908. DOI: 10.1161/CIRCHEARTFAILURE.124.012083.


Proteomic and metabolomic analyses of the human adult myocardium reveal ventricle-specific regulation in end-stage cardiomyopathies.

Hunter B, Li M, Parker B, Koay Y, Harney D, Pearson E Commun Biol. 2024; 7(1):1666.

PMID: 39702518 PMC: 11659555. DOI: 10.1038/s42003-024-07306-y.


Research progress of ankyrin repeat domain 1 protein: an updated review.

Xu X, Wang X, Li Y, Chen R, Wen H, Wang Y Cell Mol Biol Lett. 2024; 29(1):131.

PMID: 39420247 PMC: 11488291. DOI: 10.1186/s11658-024-00647-w.


ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-B-MAGE-A6 Pathway.

Diskul-Na-Ayudthaya P, Bae S, Bae Y, Van N, Kim W, Ryu S Cancers (Basel). 2024; 16(19).

PMID: 39409926 PMC: 11476229. DOI: 10.3390/cancers16193306.


Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy.

Hesselson A, Vaidya G, Kolodziej A Heart Rhythm O2. 2024; 5(8):592-596.

PMID: 39263608 PMC: 11385398. DOI: 10.1016/j.hroo.2024.06.008.


References
1.
Schnabel P, Gas H, Nohr T, Camps M, Bohm M . Identification and characterization of G protein-regulated phospholipase C in human myocardium. J Mol Cell Cardiol. 1996; 28(12):2419-27. DOI: 10.1006/jmcc.1996.0235. View

2.
Palaniyandi S, Sun L, Ferreira J, Mochly-Rosen D . Protein kinase C in heart failure: a therapeutic target?. Cardiovasc Res. 2009; 82(2):229-39. PMC: 2675930. DOI: 10.1093/cvr/cvp001. View

3.
Boateng S, Senyo S, Qi L, Goldspink P, Russell B . Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein. J Mol Cell Cardiol. 2009; 47(4):426-35. PMC: 2739242. DOI: 10.1016/j.yjmcc.2009.04.006. View

4.
Pluess M, Daeubler G, Dos Remedios C, Ehler E . Adaptations of cytoarchitecture in human dilated cardiomyopathy. Biophys Rev. 2017; 7(1):25-32. PMC: 4322184. DOI: 10.1007/s12551-014-0146-2. View

5.
El-Armouche A, Eschenhagen T . Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev. 2008; 14(4):225-41. DOI: 10.1007/s10741-008-9132-8. View